10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-000796`
Period End Date	20210630
Filing Date	20210804
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	agl-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 89 Cash Flow Statement 70 Stockholders Equity 35

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.11B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.80M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$16.34M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$28.38M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$144.56M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$338.36M	USD	Point-in-time
Redeemable common stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$9.64M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$15.74M	USD	Point-in-time
Redeemable common stock, shares issued	`TemporaryEquitySharesIssued`	76.20M	shares	Point-in-time
Current assets held for sale and discontinued operations, net	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$4.83M	USD	Point-in-time
Redeemable common stock, outstanding	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$294.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.48B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.59M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.46M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$60.47M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$58.66M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	390.88M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	249.37M	shares	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	390.88M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$117.13M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$43.70M	USD	Point-in-time
Total assets	`Assets`	$446.36M	USD	Point-in-time
Assets	`Assets`	$446.36M	USD	Point-in-time
Total assets	`Assets`	$1.70B	USD	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Liabilities	`Liabilities`	$551.46M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$162.87M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$300.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$107.60M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$97.24M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.75M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.04M	USD	Point-in-time
Current liabilities held for sale and discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$266.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$412.33M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$45.86M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$64.67M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$90.09M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$93.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$551.46M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding at December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 390,883 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$3.91M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 390,883 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$2.49M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.01B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$263.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-865.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-551.19M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.15B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$-284.73M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-169.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$446.36M	USD	Point-in-time

Income Statement 89 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$584.64M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$912.06M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$498.96M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$293.59M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$220.36M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$468.02M	USD	2 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$802.84M	USD	2 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$442.48M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$57.35M	USD	2 Qtrs
Other medical expenses	`OtherMedicalExpenses`	$53.19M	USD	2 Qtrs
Other medical expenses	`OtherMedicalExpenses`	$34.76M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$33.69M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$43.01M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$34.25M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$79.32M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$60.83M	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$3.18M	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.60M	USD	Point-in-time
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$276.02M	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.15M	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$274.55M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.52M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$7.01M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.58M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.32M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$294.85M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.22B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$797.32M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$591.73M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-310.48M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-7.09M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-298.36M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-1.25M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-74.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$4.30M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$48.00K	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$2.97M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.44M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.08M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.50M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.23M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-310.61M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-296.89M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.41M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.27M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$39.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$451.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$435.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$39.00K	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-311.06M	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-3.44M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.31M	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-297.33M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-12.43M	USD	2 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.55M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-4.34M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-2.90M	USD	2 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$126.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$65.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$129.00K	USD	2 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$275.00K	USD	2 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-12.70M	USD	2 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.61M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-4.47M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-3.03M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.01M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-7.91M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$96.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$169.00K	USD	2 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-298.85M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-7.91M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-313.92M	USD	2 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-24.01M	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.79	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.88	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.03	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.04	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	377.44M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	321.83M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	351.69M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	323.70M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.01M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-7.91M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.09M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.84M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$3.30M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$276.02M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$1.59M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.53M	USD	2 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$380.00K	USD	2 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$2.01M	USD	2 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$520.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-50.21M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-21.77M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.50M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.12M	USD	2 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$646.00K	USD	2 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$941.00K	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$306.00K	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$4.02M	USD	2 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$2.17M	USD	2 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$70.31M	USD	2 Qtrs
Proceeds from repayment of loans receivable	`ProceedsFromCollectionOfLoansReceivable`	$1.28M	USD	2 Qtrs
Proceeds from repayment of loans receivable	`ProceedsFromCollectionOfLoansReceivable`	$1.06M	USD	2 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	2 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-2.64M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-76.34M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.35M	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$1.17B	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$32.73M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$315.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$551.00K	USD	2 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	2 Qtrs
Equity and debt issuance costs and other	`PaymentOfEquityAndDebtIssuanceCostsAndOther`	$-9.77M	USD	2 Qtrs
Equity and debt issuance costs and other	`PaymentOfEquityAndDebtIssuanceCostsAndOther`	-	USD	2 Qtrs
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$118.65M	USD	2 Qtrs
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$1.52M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.14B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$31.52M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$986.62M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.33M	USD	2 Qtrs
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$4.73M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$4.73M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.28M	USD	Point-in-time

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Contingently Redeemable Common Stock, Beginning balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	390.88M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.01M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-7.91M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-460.00K	USD	2 Qtrs
Issuance of common stock, net	`StockIssuedDuringPeriodValueNewIssues`	$4.60M	USD	2 Qtrs
Issuance of common stock, net	`StockIssuedDuringPeriodValueNewIssues`	$4.60M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$386.00K	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$551.00K	USD	2 Qtrs
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$313.00K	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$315.00K	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.30M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.23M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.55M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.08M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Contingently Redeemable Common Stock, Ending balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	390.88M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.